Skip to content
Trial Eligibility
Menu

National Eye Institute Biorepository for Retinal Diseases

NCT01496625

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: - To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying genes, cells, and tissues may help them understand why some people get eye problems and others do not, or why some people respond to treatment while others do not. Researchers want to collect physical samples and personal data to develop a National Eye Institute database.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Age-Related Macular Degeneration
  • Diabetic Retinopathy
  • Von Hippel-Lindau Syndrome
  • Retinal Disease
  • Retinal Vein Occlusion

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
2 to 120 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Eye Institute (NEI)
Last updated on ClinicalTrials.gov
October 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.